A recent report out of Canada showed a high number of people experiencing vaccine-related heart problems, and the majority of those affected were young people. According to the report, which was released quietly by Public Health Ontario, there were 106 incidents of pericarditis and myocarditis in people in Ontario under the age of 25 as of August 7, which is just over half of the total of all heart inflammation hospitalizations there. Thirty one of these cases were seen in people aged 12 to 17, while 75 of the cases were noted in people aged 18 to 24. Eighty percent of all of these incidents were seen in males, and nearly 70 percent of the cases occurred following the second shot in the series. According to the report, public health units there were instructed to raise their surveillance for this particular side effect after reports emerged from Israel and the United States of similar side effects. Public Health Ontario started requiring the same-day reporting of post-vaccination myocarditis and pericarditis in June. The symptoms may appear as early as a few minutes following vaccination up to around three months following the jab. The report states: “The reporting rate of myocarditis/pericarditis was higher following the second dose of mRNA vaccine than after the first, particularly for those receiving the Moderna vaccine as the second dose of the series (regardless of the product for the first dose).” According to Public Health Ontario, the reporting rate of heart inflammation among those aged 18 to 24 was seven times higher among those who received the Moderna vaccine than those who were given Pfizer. The Pfizer vaccine is the only one being offered to those in the 12 to 17 age group, so it is not possible to make a comparison among younger people. Overall, they saw 202 visits to the emergency room across all age groups for heart problems following vaccination, 146 of which led to hospitalization and three of which required admission to the ICU. Among older individuals, 54 people aged 25 to 39 were included in the overall count, along with 44 people aged 40 and over. The two heart conditions being seen following COVID-19 vaccination are myocarditis, which is an inflammation of the heart muscle, and pericarditis, which is an inflammation of the heart’s lining. The symptoms of these problems include shortness of breath, a fluttering or pounding heart, chest pain and malaise.